Irsenontrine maleate
Modify Date: 2024-01-10 18:54:18
Irsenontrine maleate structure
|
Common Name | Irsenontrine maleate | ||
|---|---|---|---|---|
| CAS Number | 1630083-70-3 | Molecular Weight | 506.51 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H26N4O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Irsenontrine maleateIrsenontrine (E2027) maleate is an orally active and selective phosphodiesterase 9 (PDE9) inhibitor. Irsenontrine maleate can be used for the research of neurological diseases[1][2]. |
| Name | Irsenontrine maleate |
|---|
| Description | Irsenontrine (E2027) maleate is an orally active and selective phosphodiesterase 9 (PDE9) inhibitor. Irsenontrine maleate can be used for the research of neurological diseases[1][2]. |
|---|---|
| Related Catalog | |
| Target |
PDE9[1] |
| In Vivo | Irsenontrine (0.3, 3.3 mg/kg; p.o.) maleate exhibits a significant ameliorative effect on the percentage of exploration of the novel object at 3.3 mg/kg in Scopolamine-induced rats[1]. Irsenontrine (1 mg/kg; p.o.) maleate and memantine hydrochloride (1 mg/kg; p.o.) combined treatment group exhibits a significantly higher percentage of exploration of the novel object than memantine hydrochloride (1 mg/kg) alone[1]. |
| References |
| Molecular Formula | C26H26N4O7 |
|---|---|
| Molecular Weight | 506.51 |